BPTH
PINK Bio-Path Holdings, Inc.$0.0003 ↑ +0.0002 (+200.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0003
- YTD change
- -99.50%
- vs 20-day SMA
- -96.45%
- vs 200-day SMA
- -99.40%
Price ranges
Price & Performance
-0.05 (-99.42%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $1,470.4000
- BPTH is down 100% since the beginning of the year
- BPTH is down 100% over the past 12 months
- BPTH is down 99% over the past 1 month
- 0% of all BPTH investors are betting against BPTH
BPTH reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -99.5%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -40.00%
- vs 8-day SMA
- +4.35%
No alerts for BPTH in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.